By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – ARUP Laboratories will begin offering Decode Genetics' prostate cancer test in the fall under a deal announced today.

ARUP will offer Decode's ProstateCancer test to academic medical centers, public and private healthcare providers, and major hospitals in the US as part of its portfolio of tests. The test will be ordered through ARUP, which will handle patient samples and results. Decode will analyze the samples in its CAP and CLIA-certified laboratory.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.